Matthias Bodenstedt - Chief Financial Officer at MoonLake Immunotherapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
MLTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthias Bodenstedt since 12/25/2023

Holdings reported by Matthias Bodenstedt for MoonLake Immunotherapeutics

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A ordinary shares, par value $0.0001 per share 521K $30.4M $58.34 Dec 20, 2023 Direct
Class C ordinary shares, par value $0.0001 per share 294K Oct 1, 2023 Direct
Common shares, par value CHF 0.10 per share, of MoonLake AG 8.75K Oct 1, 2023 Direct Class A ordinary shares, par value $0.0001 per share

Transactions reported by Matthias Bodenstedt for MoonLake Immunotherapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.